“…8,[11][12][13] The reported prevalence of 22q11 deletions ranged from 21% to 40% for TOF-PA subjects and from 8% to 25% for cTOF subjects, whereas we found a prevalence of 13% for TOF-PA subjects and 6% for cTOF subjects. 7,8,13,22,23 The difference may be explained by the selection of more complex cases in studies from high-volume tertiary centres and by variation in the rate of termination of pregnancies among fetuses with TOF and a concomitant genetic condition. The proportion of T21 in our sample was, however, similar to what has been previously reported.…”